(Reuters) -GTCR has struck a 4.1 billion-euro ($4.80 billion) deal to buy Czech generic drug maker Zentiva from Advent International, the Financial Times reported on Wednesday, citing two people familiar with the matter.
Reuters could not immediately confirm the report.
($1 = 0.8548 euros)
(Reporting by Gnaneshwar Rajan in Bengaluru)